Andreessen Horowitz
Listed as “Octant Bio”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Company website description: Drugging the cellular mechanisms that cause disease
Bio + Health
Category source ↗Checked
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Octant Bio”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.